Navigation Links
Questcor Pharmaceuticals Announces Preliminary Operating Metrics for Third Quarter 2011
Date:9/28/2011

investments totaled $174 million.

Questcor currently expects to release its financial results for the third quarter on October 25, 2011.

"Increases in new, paid MS prescriptions are the result of increased productivity from our Specialty Sales Force which consists of 77 Acthar sales representatives," said Don M. Bailey, President and CEO of Questcor Pharmaceuticals.  "In addition, despite disruption in our nephrology selling effort as we expanded the Nephrology Sales Force from 5 to 28 sales representatives, new, paid NS prescriptions have increased from the second quarter of 2011.  The new Nephrology Sales Force has been hired and training will be completed this week.  Some of the new nephrology sales representatives and the Specialty Sales Force contributed to the increased script count in the quarter."

The Company's quarterly vial shipments continue to be subject to significant variation due to the size and timing of individual orders from its distributor, and the timing of these orders can significantly affect net sales and net income in any particular quarter. For this reason, as well as other factors causing quarter-to-quarter variability in Questcor's operating results, the Company believes that investors should consider the Company's results over several quarters when analyzing the Company's financial performance. All of the financial and prescription information above is based on preliminary estimates and analysis and are subject to change as the Company continues to close the quarter and conduct its normal financial reviews.

Prescription Information for MS, IS and NS

Because Acthar prescriptions are filled at specialty pharmacies, the Company does not receive complete information regarding either the number of prescriptions or the number of vials by therapeutic area for all of the patients being treated with Acthar.  However, Questcor is able to monitor therapeutic
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on September 28, 2011
2. Questcor Provides Updated New Paid Prescription Trends
3. UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
4. Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011
5. Questcor to Report Second Quarter 2011 Earnings and Conduct Conference Call on July 26, 2011
6. Questcor Proxy Proposals All Approved at 2011 Shareholder Meeting
7. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
8. Questcor to Report First Quarter 2011 Earnings and Conduct Conference Call on April 26, 2011
9. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011
10. Questcor Pharmaceuticals to Present at the Needham Healthcare Conference
11. Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2015)... , July 6, 2015 Nihon ... international symposium on Medical-Engineering Collaboration "Medicine Definitely ... July 10, 2015 in Tokyo, Japan ... its medical applied research will present their achievements ... and a new industry produced with 8K technology. ...
(Date:7/4/2015)... 2015 Adding SIR-Spheres® Y-90 ... unresectable metastatic colorectal cancer in the liver (mCRC) ... Patients with unresectable metastatic colorectal cancer (mCRC) ... the greatest improvement in Progression-Free Survival (PFS) in ... resin microspheres to a current first-line chemotherapy regimen, ...
(Date:7/3/2015)... , July 3, 2015 ... "Cardiac Monitoring & Cardiac Rhythm Management Market ECG, ... Monitoring, Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, ... by MarketsandMarkets, the global Cardiac Monitoring (CM) and ... to reach $26,646.5 Million by 2020 from $21,137.7 ...
Breaking Medicine Technology:Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4
... Ontario , June 18 CardioGenics Holdings Inc. (OTC ... analyzer and products for the immunoassay segment of the In-Vitro Diagnostics ... , , ... The 2-page profile was prepared by Redington, Inc., a leading life ...
... June 18 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese,Medicines Company (the ... pharmaceutical company focusing on the development, manufacturing,marketing and selling of ... financial results for the quarter ended March 31, 2010 ... Quarter Ended March 31, 2010, -- Net ...
Cached Medicine Technology:New Corporate Profile Posted On CardioGenics' Website 2Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 2Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 3Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 4Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 5Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 6Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 7Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 8Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 9Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 10Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 11Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 12Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 13Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 14Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 15
(Date:7/6/2015)... ... 06, 2015 , ... The School of Public Health at ... three-year effort to reduce rates of diabetes and cardiovascular disease in African-American neighborhoods ... Morehouse School of Medicine’s Prevention Research Center and the Satcher Health Leadership Institute ...
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is now ... patients. Kybella is a non-surgical method to dissolve fat cells and is ... to severe fat deposits under the chin, commonly known as a double chin. Dr. ...
(Date:7/6/2015)... ... July 06, 2015 , ... Orthopaedic & Spine ... 100th case using SpineFrontier’s® PedFuse® REmind® Screws. The operation took place on Tuesday, ... The procedure was an L5-S1 posterior lumbar interbody fusion on a 69 year ...
(Date:7/6/2015)... , ... July 06, 2015 , ... Thanks to donations ... and Hospice received the Music & Memory Certification for hospice patients and adult day ... of music not only to patients but also to their families and volunteers. Music ...
(Date:7/5/2015)... (PRWEB) , ... July 06, 2015 , ... ... ancillary benefits market, is excited to announce the next generation of PrimeStar Individual ... Advantage plans to now include two network options—Maximum Allowable Charge (MAC) and usual, ...
Breaking Medicine News(10 mins):Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... Nov. 5 The law firm of Baron & ... asbestos exposure,lawsuit filed on behalf of an 81-year-old man ... reached a day before the jury would have,determined the ... Attorneys John Langdoc and Eric Brown from Baron & ...
... Launched Inpatient Certification ... ... Information Technology (CCHIT(sm)) today announced that the,Eclypsis Corporation(R) (Nasdaq: ECLP ... module of Sunrise Clinical Manager(TM),is CCHIT Certified(sm), and meets the Commission,s ...
... detection combined with MDCT improves radiologists ability to detect ... treated without increasing interpretation time according to a recent ... France. , The comparison of a current examination with ... Philippe A. Grenier, MD, lead author of the study. ...
... sound- and light-proof tanks with high-salt waterfloatingis an ... has been shown by Sven-ke Bood, who recently ... from Karlstad University in Sweden. , The ... was improved, patients felt more optimistic, and the ...
... American College of Physicians (ACP) today renewed its call on ... reimbursements set to take effect Jan. 1 with at least ... a way that does not make the problem worse in ... related subspecialists and medical students reacted to the final physician ...
... Fla. -- If you go to the hospital within one ... heart attack, your chances of getting proper treatment are nearly ... hours before seeking treatment, according to results presented today at ... , This research should emphasize to patients that getting help ...
Cached Medicine News:Health News:Baron & Budd, P.C., Announces $3.6 Million Settlement in California Asbestos Lawsuit 2Health News:Eclipsys Sunrise Acute Care Receives CCHIT Certification 2Health News:Eclipsys Sunrise Acute Care Receives CCHIT Certification 3Health News:Eclipsys Sunrise Acute Care Receives CCHIT Certification 4Health News:Floating effective for stress and pain 2Health News:Congress called on to replace 'devastating' cuts in Medicare reimbursements by ACP 2Health News:Mayo Clinic identifies new risk factor for heart attack patients 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: